Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation

Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation

(2021) Ruth Van Daele et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

(2021) Juergen Prattes et al.   CLINICAL MICROBIOLOGY AND INFECTION

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

(2021) Paul E. Verweij et al.   INTENSIVE CARE MEDICINE

A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation

(2021) Ruth Van Daele et al.   Microorganisms

Influenza-Associated Disseminated Aspergillosis in a 9-Year-Old Girl Requiring ECMO Support

(2021) Natalia Mendoza-Palomar et al.   Journal of Fungi

Implementation of a Dual-Column Liquid Chromatography-Tandem Mass-Spectrometry Method for the Quantification of Isavuconazole in Clinical Practice

(2021) Dietmar Enko et al.   Journal of Laboratory Physicians

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

(2021) Jean-Pierre Gangneux et al.   Lancet Respiratory Medicine

Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center

(2020) Andrew M Borman et al.   MEDICAL MYCOLOGY

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

(2020) Christoph Zurl et al.   Journal of Fungi

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

(2020) Philipp Koehler et al.   LANCET INFECTIOUS DISEASES

Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy

(2019) E Furfaro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories

(2019) Federico Pea et al.   THERAPEUTIC DRUG MONITORING

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

(2019) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation

(2019) Yanjun Zhao et al.   PHARMACOTHERAPY

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

(2018) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy

(2018) Jeffrey D Jenks et al.   Drug Design Development and Therapy

Optimising drug dosing in patients receiving extracorporeal membrane oxygenation

(2018) Vesa Cheng et al.   Journal of Thoracic Disease

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

(2018) Alexander F A D Schauwvlieghe et al.   Lancet Respiratory Medicine

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

(2018) David R. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Variability and exposure–response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases

(2018) Thomas Kaindl et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

No Dose Adjustment Necessary for Isavuconazole in Obese Patients

(2016) Amit Desai et al.   Open Forum Infectious Diseases

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

(2012) Stijn I. Blot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation

(2009) I. Spriet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES